CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis

Abstract The aim of the study was to assess the predictors of major adverse cardiovascular events (MACE) in patients with systemic sclerosis (SSc) without pulmonary arterial hypertension. The study comprised 68 patients with SSc who were followed up for the median time of 99 (96; 107) months. The ma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Klaudia Gieszczyk-Strózik, Maciej T. Wybraniec, Małgorzata Widuchowska, Ligia Brzezińska-Wcisło, Przemysław Kotyla, Eugeniusz Kucharz, Katarzyna Mizia-Stec
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7a6fe92b57744d8a9d0c70056d52b322
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7a6fe92b57744d8a9d0c70056d52b322
record_format dspace
spelling oai:doaj.org-article:7a6fe92b57744d8a9d0c70056d52b3222021-12-02T17:37:23ZCHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis10.1038/s41598-021-99215-x2045-2322https://doaj.org/article/7a6fe92b57744d8a9d0c70056d52b3222021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-99215-xhttps://doaj.org/toc/2045-2322Abstract The aim of the study was to assess the predictors of major adverse cardiovascular events (MACE) in patients with systemic sclerosis (SSc) without pulmonary arterial hypertension. The study comprised 68 patients with SSc who were followed up for the median time of 99 (96; 107) months. The main exclusion criteria involved tricuspid regurgitation maximal velocity > 2.8 m/s and structural heart disease. At baseline the patients underwent clinical assessment of cardiovascular risk factors, 6-min walk test, transthoracic echocardiography and biomarker testing, including growth differentiation factor 15 (GDF-15). The primary composite endpoint was onset of MACE defined as death, myocardial infarction, myocardial revascularization and hospitalization for heart failure. The follow-up consisted of outpatient visits at 1 year intervals and telephone interview every 6 months. The baseline analysis revealed that chronic kidney disease (HR 28.13, 95%CI 4.84–163.38), lung fibrosis on high resolution computed tomography (HR 4.36, 95%CI 1.04–18.26) and GDF-15 concentration (unit HR 1.0006, 95%CI 1.0002–1.0010) were independent predictors of MACE occurrence. CHLD (Chronic kidney disease, Hypertension, hyperLipidaemia, Diabetes mellitus) score was formulated which assigned 1 point for the presence of arterial hypertension, hyperlipidaemia, diabetes mellitus and chronic kidney disease. After inclusion of CHLD score in Cox proportional model, it remained the only independent predictor of MACE onset (unit HR per 1 point 3.46; 95%CI 2.06–5.82, p < 0.0001). Joint assessment of traditional risk factors in the form of CHLD score may serve as a reliable predictor of long-term outcome in patients with SSc without pulmonary arterial hypertension.Klaudia Gieszczyk-StrózikMaciej T. WybraniecMałgorzata WiduchowskaLigia Brzezińska-WcisłoPrzemysław KotylaEugeniusz KucharzKatarzyna Mizia-StecNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Klaudia Gieszczyk-Strózik
Maciej T. Wybraniec
Małgorzata Widuchowska
Ligia Brzezińska-Wcisło
Przemysław Kotyla
Eugeniusz Kucharz
Katarzyna Mizia-Stec
CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
description Abstract The aim of the study was to assess the predictors of major adverse cardiovascular events (MACE) in patients with systemic sclerosis (SSc) without pulmonary arterial hypertension. The study comprised 68 patients with SSc who were followed up for the median time of 99 (96; 107) months. The main exclusion criteria involved tricuspid regurgitation maximal velocity > 2.8 m/s and structural heart disease. At baseline the patients underwent clinical assessment of cardiovascular risk factors, 6-min walk test, transthoracic echocardiography and biomarker testing, including growth differentiation factor 15 (GDF-15). The primary composite endpoint was onset of MACE defined as death, myocardial infarction, myocardial revascularization and hospitalization for heart failure. The follow-up consisted of outpatient visits at 1 year intervals and telephone interview every 6 months. The baseline analysis revealed that chronic kidney disease (HR 28.13, 95%CI 4.84–163.38), lung fibrosis on high resolution computed tomography (HR 4.36, 95%CI 1.04–18.26) and GDF-15 concentration (unit HR 1.0006, 95%CI 1.0002–1.0010) were independent predictors of MACE occurrence. CHLD (Chronic kidney disease, Hypertension, hyperLipidaemia, Diabetes mellitus) score was formulated which assigned 1 point for the presence of arterial hypertension, hyperlipidaemia, diabetes mellitus and chronic kidney disease. After inclusion of CHLD score in Cox proportional model, it remained the only independent predictor of MACE onset (unit HR per 1 point 3.46; 95%CI 2.06–5.82, p < 0.0001). Joint assessment of traditional risk factors in the form of CHLD score may serve as a reliable predictor of long-term outcome in patients with SSc without pulmonary arterial hypertension.
format article
author Klaudia Gieszczyk-Strózik
Maciej T. Wybraniec
Małgorzata Widuchowska
Ligia Brzezińska-Wcisło
Przemysław Kotyla
Eugeniusz Kucharz
Katarzyna Mizia-Stec
author_facet Klaudia Gieszczyk-Strózik
Maciej T. Wybraniec
Małgorzata Widuchowska
Ligia Brzezińska-Wcisło
Przemysław Kotyla
Eugeniusz Kucharz
Katarzyna Mizia-Stec
author_sort Klaudia Gieszczyk-Strózik
title CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
title_short CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
title_full CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
title_fullStr CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
title_full_unstemmed CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
title_sort chld score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/7a6fe92b57744d8a9d0c70056d52b322
work_keys_str_mv AT klaudiagieszczykstrozik chldscoreanewscorebasedontraditionalriskfactorevaluationandlongtermcardiovascularoutcomesinpatientswithsystemicsclerosis
AT maciejtwybraniec chldscoreanewscorebasedontraditionalriskfactorevaluationandlongtermcardiovascularoutcomesinpatientswithsystemicsclerosis
AT małgorzatawiduchowska chldscoreanewscorebasedontraditionalriskfactorevaluationandlongtermcardiovascularoutcomesinpatientswithsystemicsclerosis
AT ligiabrzezinskawcisło chldscoreanewscorebasedontraditionalriskfactorevaluationandlongtermcardiovascularoutcomesinpatientswithsystemicsclerosis
AT przemysławkotyla chldscoreanewscorebasedontraditionalriskfactorevaluationandlongtermcardiovascularoutcomesinpatientswithsystemicsclerosis
AT eugeniuszkucharz chldscoreanewscorebasedontraditionalriskfactorevaluationandlongtermcardiovascularoutcomesinpatientswithsystemicsclerosis
AT katarzynamiziastec chldscoreanewscorebasedontraditionalriskfactorevaluationandlongtermcardiovascularoutcomesinpatientswithsystemicsclerosis
_version_ 1718379891075842048